Matthew Spinelli

Strategies to Predict Success on Long-Acting Therapy in Real-World Settings for HIV (SPLASH)

National Institute of Allergy and Infectious Diseases · R01

PI · $772.3K · University of California, San Francisco

InSTagrAn: A Scalable Telehealth and Urine Tenofovir Self-Testing Intervention to Enhance PrEP Adherence Among People Who Use Methamphetamine

National Institute on Drug Abuse · R01

PI · $644.2K · Graduate School of Public Health and Health Policy

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $1.6M · University of California, San Francisco

Developing a U.S. National Cohort to Improve Virologic Suppression Among Stimulant-Using Men Living with HIV.

National Institute on Drug Abuse · UH3

Contact PI · $3.6M · University of California, San Francisco

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

Principal investigator · Recruiting

University of California, San Francisco

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Principal investigator · Recruiting · Early phase 1

University of California, San Francisco

PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men

Principal investigator · Completed

University of California, San Francisco